Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Feverfew extract + vitamin E is a topical antioxidant combination developed for enhanced photoprotection. It consists of a parthenolide-free extract of *Tanacetum parthenium* (feverfew) and alpha-tocopherol (vitamin E). This combination is specifically designed to mitigate oxidative stress and reactive oxygen species (ROS) generation caused by boundary region wavelengths of light, including the longest ultraviolet A (LUVA, 380–400 nm) and high energy visible light (HEVL, 400–760 nm). These wavelengths are known to penetrate deeper into the skin and induce hyperpigmentation and premature aging, often bypassing standard UV filters. By neutralizing ROS, the combination provides broad-spectrum antioxidant protection, positioning it as a functional additive for sunscreens to prevent skin damage and pigmentary disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on feverfew extract + vitamin E.